BACKGROUND: Human ehrlichioses are emerging life-threatening diseases transmitted by ticks. Animal models have been developed to study disease development; however, there is no valid small animal model that uses a human ehrlichial pathogen. The objective of this study was to develop a mouse model for ehrlichiosis with the newly discovered human pathogen, Ehrlichia muris-like agent (EMLA). METHODS: Three strains of mice were inoculated with different doses of EMLA by the intravenous, intraperitoneal, or intradermal route and evaluated for clinical and pathologic changes during the course of infection. RESULTS: EMLA infected C57Bl/6, BALB/c, and C3H/HeN mice and induced lethal or persistent infection in a route- and dose-dependent manner. The clinical chemistry and hematologic changes were similar to those of human infection by Ehrlichia chaffeensis or EMLA. Bacterial distribution in tissues differed after intradermal infection, compared with the distribution after intravenous or intraperitoneal injection. Lethal infection did not cause remarkable pathologic changes, but it caused fluid imbalance. EMLA infection of endothelium and mononuclear cells likely plays a role in the severe outcome. CONCLUSIONS: The EMLA mouse model mimics human infection and can be used to study pathogenesis and immunity and for development of a vector transmission model of ehrlichiosis.
BACKGROUND:Human ehrlichioses are emerging life-threatening diseases transmitted by ticks. Animal models have been developed to study disease development; however, there is no valid small animal model that uses a human ehrlichial pathogen. The objective of this study was to develop a mouse model for ehrlichiosis with the newly discovered human pathogen, Ehrlichia muris-like agent (EMLA). METHODS: Three strains of mice were inoculated with different doses of EMLA by the intravenous, intraperitoneal, or intradermal route and evaluated for clinical and pathologic changes during the course of infection. RESULTS: EMLA infected C57Bl/6, BALB/c, and C3H/HeN mice and induced lethal or persistent infection in a route- and dose-dependent manner. The clinical chemistry and hematologic changes were similar to those of humaninfection by Ehrlichia chaffeensis or EMLA. Bacterial distribution in tissues differed after intradermal infection, compared with the distribution after intravenous or intraperitoneal injection. Lethal infection did not cause remarkable pathologic changes, but it caused fluid imbalance. EMLA infection of endothelium and mononuclear cells likely plays a role in the severe outcome. CONCLUSIONS: The EMLA mouse model mimics humaninfection and can be used to study pathogenesis and immunity and for development of a vector transmission model of ehrlichiosis.
Authors: C D Paddock; J W Sumner; G M Shore; D C Bartley; R C Elie; J G McQuade; C R Martin; C S Goldsmith; J E Childs Journal: J Clin Microbiol Date: 1997-10 Impact factor: 5.948
Authors: Kazutoyo Miura; Andrew C Orcutt; Olga V Muratova; Louis H Miller; Allan Saul; Carole A Long Journal: Vaccine Date: 2007-11-20 Impact factor: 3.641
Authors: Bobbi S Pritt; Lynne M Sloan; Diep K Hoang Johnson; Ulrike G Munderloh; Susan M Paskewitz; Kristina M McElroy; Jevon D McFadden; Matthew J Binnicker; David F Neitzel; Gongping Liu; William L Nicholson; Curtis M Nelson; Joni J Franson; Scott A Martin; Scott A Cunningham; Christopher R Steward; Kay Bogumill; Mary E Bjorgaard; Jeffrey P Davis; Jennifer H McQuiston; David M Warshauer; Mark P Wilhelm; Robin Patel; Vipul A Trivedi; Marina E Eremeeva Journal: N Engl J Med Date: 2011-08-04 Impact factor: 91.245
Authors: Prashant Kapoor; Patricia T Greipp; Eric W Schaefer; Sumithra J Mandrekar; Arif H Kamal; Natalia C Gonzalez-Paz; Shaji Kumar; Philip R Greipp Journal: Mayo Clin Proc Date: 2010-07-15 Impact factor: 7.616
Authors: Bobbi S Pritt; Michelle E J Allerdice; Lynne M Sloan; Christopher D Paddock; Ulrike G Munderloh; Yasuko Rikihisa; Tomoko Tajima; Susan M Paskewitz; David F Neitzel; Diep K Hoang Johnson; Elizabeth Schiffman; Jeffrey P Davis; Cynthia S Goldsmith; Curtis M Nelson; Sandor E Karpathy Journal: Int J Syst Evol Microbiol Date: 2017-07-12 Impact factor: 2.747
Authors: Geoffrey E Lynn; Nicole Y Burkhardt; Roderick F Felsheim; Curtis M Nelson; Jonathan D Oliver; Timothy J Kurtti; Ingrid Cornax; M Gerard O'Sullivan; Ulrike G Munderloh Journal: Appl Environ Microbiol Date: 2019-07-01 Impact factor: 4.792
Authors: Derek D Jones; Rachael Racine; Susan T Wittmer; Louise Harston; Amber M Papillion; Lisa M Dishaw; Troy D Randall; David L Woodland; Gary M Winslow Journal: Infect Immun Date: 2015-03-16 Impact factor: 3.441
Authors: Geoffrey E Lynn; Jonathan D Oliver; Curtis M Nelson; Roderick F Felsheim; Timothy J Kurtti; Ulrike G Munderloh Journal: PLoS One Date: 2015-03-17 Impact factor: 3.240
Authors: Geoffrey E Lynn; Jonathan D Oliver; Ingrid Cornax; M Gerard O'Sullivan; Ulrike G Munderloh Journal: Parasit Vectors Date: 2017-01-28 Impact factor: 3.876
Authors: Arathy D S Nair; Chuanmin Cheng; Chanran K Ganta; Michael W Sanderson; Arthur R Alleman; Ulrike G Munderloh; Roman R Ganta Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240